2026-01-26 - Analysis Report
**Report for JPMorgan Chase (JPM)**

**Company Overview**
JPMorgan Chase is a multinational banking and financial services company.

**Market Performance**

* **Cumulative Return**:
    - Review Stock (JPM): 197.11%
    - Comparison Stock (S&P 500, VOO): 126.41%
* **Divergence**: 67.60, with a relative divergence of 73.40%

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|--------|
| 2016-2018  | 21.0% | 17.9% | 9.0% | 1.2 | 265.8B |
| 2017-2019  | 32.0% | 17.9% | 7.0% | 1.1 | 379.5B |
| 2018-2020  | -8.0% | 41.9% | -32.0% | 1.2 | 345.9B |
| 2019-2021  | 47.0% | 41.9% | -18.0% | 1.2 | 431.1B |
| 2020-2022  | -11.0% | 41.8% | -18.0% | 1.1 | 365.1B |
| 2021-2023  | 29.0% | 31.7% | 9.0% | 0.9 | 463.1B |
| 2022-2024  | 83.0% | 27.2% | 53.0% | 0.9 | 652.5B |
| 2023-2025  | 166.0% | 23.8% | 90.0% | 0.9 | 877.2B |

**Recent Stock Price Fluctuations**

* Close: $297.72
* Last-market: -$1.95
* 5-day SMA: $303.72
* 20-day SMA: $318.88
* 60-day SMA: $313.43

**Indicator Analysis**

* **Market Risk Indicator (MRI)**: 0.70, suggesting a Medium investment risk
* **RSI**: 28.31, indicating oversold territory
* **PPO**: -1.04, suggesting a strong sell signal
* **Expected Return (%)**: 9.80%, suggesting a potential long-term excess return compared to the S&P 500

**Recent News & Significant Events**

* Jan 25: Trump Lawsuit Puts JPMorgan Legal Risks And Valuation In Focus
* Jan 25: Country Trust Bank Sells 9,340 Shares of JPMorgan Chase & Co. $JPM
* Jan 13: JPMorgan profit beats estimates on trading boom, shares hit by weaker investment banking
* Jan 13: JPMorgan stock will bounce back, Jim Cramer says
* Jan 23: JPMorgan Chase: Post-Earnings Weakness Is An Opportunity
* Jan 23: JPMorgan Chase, a $4.4T bank, offers public 2-hour 2026 update

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.27 (~Buy)
- Opinions: 23
- Target Price (avg/high/low): 342.57 / 400.00 / 280.00

**Comprehensive Analysis (Summary)**

Based on the provided data, JPMorgan Chase has shown impressive growth in recent years, with a cumulative return of 197.11% outperforming the S&P 500 by 70.70%. The company's alpha and beta analysis suggest a mix of strong and weak performance across different time periods.

The recent stock price fluctuations indicate a sharp decline, with a 5-day SMA of $303.72, 20-day SMA of $318.88, and 60-day SMA of $313.43.

The technical indicators suggest a sell signal, with an RSI of 28.31 and a PPO of -1.04. The MRI indicates a medium investment risk.

Recent news and significant events have highlighted the company's legal risks and valuation concerns, as well as its potential for a strong bounce back.

The analyst consensus suggests a strong buy recommendation with a mean rating of 2.27 and a target price of $342.57.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.